K-numberK241702
Device nameCROSSLEAD 0.014inch
ApplicantAsahi Intecc Co., Ltd.
Product codeDQX
Device classClass II
Decision dateFeb 6, 2025
DecisionSubstantially Equivalent
Regulation870.1330
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The CROSSLEAD 0.014inch is a steerable guide wire designed to direct a catheter to desired anatomical locations in the peripheral vasculature during diagnostic or interventional procedures. It has a maximum diameter of 0.014 inches (0.36mm) and is available in lengths of 100cm, 200cm, 235cm, and 300cm. The device is not intended for neurovascular use.

Technological characteristics

The device features a hybrid nitinol and stainless-steel core wire with a stainless-steel inner coil and platinum-nickel outer coil. Key differences from the predicate ASAHI Gladius include a modified coil structure and core shape. Like the predicate, it has hydrophilic and hydrophobic coatings, is sterilized via ethylene oxide, and is available in both straight and pre-shaped designs.

Test standards cited

Not stated in this summary. The document describes non-clinical laboratory testing performed (tensile strength, torque strength, torqueability, tip flexibility, coating integrity, catheter compatibility, visual inspection, corrosion resistance, kink resistance, radio-detectability, dimensional verification, and acute particulate characterization) but does not cite specific consensus standards or test method numbers.

Substantial equivalence argument

The device has the same intended use as the predicate (peripheral vascular catheter guidance during diagnostic or interventional procedures). In vitro bench testing demonstrated the subject device met all acceptance criteria and performed similarly to predicate and reference devices. Biocompatibility was confirmed through standard assessment endpoints. Although coil structure and core shape differ, the overall components, materials, sterilization method, shelf life, and operating principles remain substantially similar, establishing functional and safety equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →